Dilber Rawat

Surya Pharmaceutical Limited

Surya Pharmaceutical is the the premier integrated pharmaceuticals company in India. Its business focuses on the manufacture and marketing of pharmaceuticals products and services to clients across the globe, and its product portfolio includes a range of Active Pharmaceutical Ingredients (API's), Finished Drug Formulations (FDF's), Fine Intermediates, Herbal Products, and Mint/Menthol Derivatives. It is a flagship company of Surya which has business interests in Education, Healthcare, Communications, and Infrastructure. The company is an ISO 9001-2000 WHO GMP certified organization with nine state of the art manufacturing units positioned in multiple locations across the northern region in India. With a focus on innovation and quality, the company has demonstrated unparalled growth to a current turnover of more than Rs. 7 billion and is listed on both the Bombay Stock Exchange and the National Stock Exchange.